Your browser doesn't support javascript.
loading
2016 Children's Tumor Foundation conference on neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis.
Fisher, Michael J; Belzberg, Allan J; de Blank, Peter; De Raedt, Thomas; Elefteriou, Florent; Ferner, Rosalie E; Giovannini, Marco; Harris, Gordon J; Kalamarides, Michel; Karajannis, Matthias A; Kim, AeRang; Lázaro, Conxi; Le, Lu Q; Li, Wei; Listernick, Robert; Martin, Staci; Morrison, Helen; Pasmant, Eric; Ratner, Nancy; Schorry, Elisabeth; Ullrich, Nicole J; Viskochil, David; Weiss, Brian; Widemann, Brigitte C; Zhu, Yuan; Bakker, Annette; Serra, Eduard.
Afiliação
  • Fisher MJ; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Belzberg AJ; Department of Pediatrics, The Perelman School of Medicine at The University of Pennsylvania, Philadelphia, Pennsylvania.
  • de Blank P; Department of Neurosurgery, The Johns Hopkins Hospital, Baltimore, Maryland.
  • De Raedt T; Division of Oncology and Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
  • Elefteriou F; Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Ferner RE; Center for Skeletal Medicine and Biology, Department of Molecular and Human Genetics and Orthopedic Surgery, Baylor College of Medicine, Houston, Texas.
  • Giovannini M; Neurofibromatosis Centre, Guy's and St. Thomas NHS Foundation Trust, London, United Kingdom.
  • Harris GJ; Department of Head and Neck Surgery, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
  • Kalamarides M; Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
  • Karajannis MA; Department of Neurosurgery, Hospital Pitie-Salpetriere, AP-HP, Paris, France; Université Pierre et Marie Curie, Sorbonne Universités, Paris, France.
  • Kim A; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Lázaro C; Division of Oncology, Children's National Medical Center, Washington, District of Columbia.
  • Le LQ; Hereditary Cancer Program, Catalan Institute of Oncology (ICO-IDIBELL-CIBERONC), L'Hospitalet de Llobregat, Barcelona, Spain.
  • Li W; Department of Dermatology and Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas.
  • Listernick R; Department of Pediatrics, Department of Biochemistry & Molecular Biology, Penn State University College of Medicine, Hershey, Pennsylvania.
  • Martin S; Division of Academic General Pediatrics, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.
  • Morrison H; Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
  • Pasmant E; National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Ratner N; Leibniz Institute on Aging Research, Fritz Lipmann Institute, Jena, Germany.
  • Schorry E; EA7331 and Cochin Hospital, Paris Descartes University, Faculty of Pharmacy of Paris, France.
  • Ullrich NJ; Division of Experimental Hematology and Cancer Biology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio.
  • Viskochil D; Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
  • Weiss B; Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Widemann BC; Division of Medical Genetics, Department of Pediatrics, University of Utah, Salt Lake City, Utah.
  • Zhu Y; Division of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
  • Bakker A; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Serra E; The Gilbert Family Neurofibromatosis Institute, Centers for Cancer and Immunology Research and Neuroscience Research, Children's National Medical Center, Washington, District of Columbia.
Am J Med Genet A ; 176(5): 1258-1269, 2018 05.
Article em En | MEDLINE | ID: mdl-29681099
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Neurofibromatose 2 / Neurofibromatose 1 / Neurofibromatoses / Neurilemoma Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Neurofibromatose 2 / Neurofibromatose 1 / Neurofibromatoses / Neurilemoma Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article